Gary Phillips
Chief Executive Officer bei SYNTARA LIMITED
Vermögen: 70 677 $ am 31.03.2024
Profil
Gary Jonathan Phillips is currently the Chief Executive Officer, MD & Director at Syntara Ltd.
He is also an Independent Non-Executive Director at Arovella Therapeutics Ltd.
and a Member of the Australian Institute of Co. Directors.
Previously, he served as the Chief Executive Officer-Hungary at Ciba-Geigy AG from 1992 to 1998.
He also held the position of Chief Executive Officer-Pharmaceutical Division at Novartis Australia Pty Ltd.
and Area Director-Asia at Novartis AG.
Mr. Phillips holds an MBA from Henley Business School Ltd.
and an undergraduate degree from The University of Nottingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2023 | 722 222 ( 0,08% ) | 70 677 $ | 31.03.2024 |
Aktive Positionen von Gary Phillips
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNTARA LIMITED | Chief Executive Officer | 12.03.2013 |
| AROVELLA THERAPEUTICS LIMITED | Director/Board Member | 01.07.2022 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Gary Phillips
| Unternehmen | Position | Ende |
|---|---|---|
Ciba-Geigy AG
 Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Corporate Officer/Principal | 01.01.1998 |
| NOVARTIS AG | Corporate Officer/Principal | 31.12.1996 |
Novartis Australia Pty Ltd.
 Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Corporate Officer/Principal | - |
Ausbildung von Gary Phillips
| Henley Business School Ltd. | Masters Business Admin |
| The University of Nottingham | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| SYNTARA LIMITED | Health Technology |
| NOVARTIS AG | Health Technology |
| AROVELLA THERAPEUTICS LIMITED | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Ciba-Geigy AG
Ciba-Geigy AG Pharmaceuticals: MajorHealth Technology Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland. | Health Technology |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
Novartis Australia Pty Ltd.
Novartis Australia Pty Ltd. BiotechnologyHealth Technology Novartis Australia Pty Ltd. engages in the marketing and wholesale of pharmaceutical products in Australia. The company is headquartered in North Ryde, Australia. | Health Technology |
